Who’s Hired? IGBA Names IPA’s Jain As Chair
As Celltrion Chairman Steps Down And Synthon Names CEO
Executive Summary
The International Generic and Biosimilar Medicines Association has named the IPA’s Sudarshan Jain as its new chair. While Celltrion’s chairman has stepped down, Coherus has added two members to its board of directors and Synthon has appointed a new CEO.
You may also be interested in...
IPA’s Jain Predicts 3-4 Weeks To Meet Indian Shortages
Speaking exclusively to Generics Bulletin, Indian Pharmaceutical Alliance secretary general Sudarshan Jain says that India’s needs for COVID drugs like favipiravir, remdesivir and tocilizumab will be met “in the near future.” Current IGBA chair Jain also talks about global collaboration by governments and donors for equal vaccine distribution through the Access to COVID-19 Tools Accelerator.
India’s Big Eight Make Digital Leap With Two Acquisitions
In an unprecedented move, eight of India’s top pharma companies, including Sun Pharma, Cipla, Torrent and Lupin, have set up a common vehicle for digitization initiatives. Having acquired local market research firm AIOCD AWACS and B2B platform Pharmarack, could the mandate extend to other services?
IGBA Kicks Off Biosimilars Week
A week-long global educational initiative to raise awareness of biosimilars has been launched by the IGBA.